NCT00437216View on ClinicalTrials.gov

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

CompletedOBSERVATIONAL
Enrollment

2,488

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Psoriasis
Interventions
DRUG

Clobetasol Propionate, 0.05%

Apply twice daily for 2 or 4 weeks as monotherapy

DRUG

Clobetasol propionate, 0.05% Spray

Apply twice daily for 2 or 4 weeks as add-on therapy

Trial Locations (1)

76117

DHC Dimensional HealthCare, Inc. (Clinical Research Organization), Cedar Knolls

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY